CompletedNot Applicable

Prevention of Neurosurgical Wound Infections

United States214 participantsStarted 2009-05-13

Plain-language summary

The goal of this study is to determine whether injecting the antibiotic vancomycin directly into surgical wounds can decrease the rate of infection following implantation of neurosurgical devices.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * deep brain stimulators (DBS) * spinal cord stimulators (SCS) * motor cortex stimulators (MCS) * vagus nerve stimulators (VNS) * peripheral nerve stimulators (PNS) Exclusion Criteria: * allergies to vancomycin * immunocompromise or taking immunosuppressant drugs * currently taking aminoglycoside antibiotics, such as amikacin, gentamicin, neomycin, streptomycin or tobramycin * diagnosed renal failure * currently undergoing chemotherapy * pregnancy * non-english speakers * unable to return for follow-up, or unable to be contacted by telephone

What they're measuring

Incidence of Infection That Requires Removal of the Neurosurgical Device

Timeframe: Six months post-operation

Trial details

NCT IDNCT00915967

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-12-19

Results submitted2019-01-17

View on ClinicalTrials.gov More Surgical Wound Infections trials